#402 ‒ NMR blood analysis: how heart disease risk, insulin resistance, inflammation, and mortality risk can be assessed from a single blood sample | Jim Otvos, Ph.D.

The clinical application of nuclear magnetic resonance (NMR) spectroscopy offers a superior method for assessing cardiovascular and metabolic health by quantifying lipoprotein particle concentration rather than relying solely on traditional cholesterol mass measurements. Biophysical chemist Jim Otvos, who pioneered this technology, explains that LDL particle number (LDL-P) provides a more accurate reflection of atherogenic risk than standard LDL cholesterol. Beyond lipids, NMR analysis now extracts complex metabolic signatures, including the Metabolic Vulnerability Index (MVX), which integrates inflammatory markers like GlycA, citrate, and branched-chain amino acids to predict mortality risk and metabolic frailty. While this diagnostic approach provides high-density data from a single blood sample, its widespread clinical adoption remains limited by existing insurance reimbursement models and the lack of proactive diagnostic infrastructure, despite the technology's potential to identify metabolic dysfunction long before traditional markers like blood glucose rise.